YOON&YANG
Yoon & Yang’s Health Care Team promptly devises a thorough response strategy for clients by leveraging its industry insights accumulated in various regulations and dispositions, thereby offering the optimal solution tailored to each client. Having successfully advocated for client interests in numerous litigations related to regulations and dispositions of the Ministry of Food and Drug Safety (MFDS), the Healthcare Team continues to provide multifaceted services to its clients in the healthcare industry in this fast-changing regulatory environment.

Key Services

Responding to hearing procedures and litigation for suspension of execution and revocation related to MFDS regulations and dispositions
  • Pharmaceutical/Bio
  • Medical devices
  • Cosmetics
  • Food products

Responding to the Ministry of Health and Welfare and the health insurance system
Responding to healthcare sector IP disputes, including the patent linkage system
Responding to antitrust & competition issues in the healthcare sector
Healthcare sector IPOs and M&As
Healthcare-related technology licensing

Representative Cases

  • Represented Medytox in its response to the MFDS manufacturing and sales suspension order, disposition to cancel product authorization, recall and destruction order, and represented the same in an application for a suspension of execution and litigation on the merits of each
  • Represented Kolon Life Science in its response to the MFDS manufacturing and sales suspension order, disposition to cancel product authorization, recall and destruction order
  • Represented SK Chemical in litigation seeking for a revocation and suspension of execution of a disposition to adjust the upper limit amount of Promac Tab
  • Represented SK Chemical in a patent infringement litigation related to a pneumococcal conjugate vaccine
  • Represented a client in a patent invalidation litigation and patent infringement litigation related to an extension of the term of a pharmaceutical patent
  • Represented a client in a patent infringement litigation related to a pharmaceutical patent
  • Responded to the MFDS disposition related to rebates
  • Advised on the patent linkage system
  • Advised a healthcare company on a management rights dispute and responded to its criminal case
  • Responded to a pharmaceutical company’s antitrust and competition law violation case
  • Advised a multinational pharmaceutical company on clinical trials
  • Advised on a joint development and license agreement related to a drug product
  • Advised a healthcare company on the Capital Markets Act
  • Advised a healthcare company on M&A
  • Advised a healthcare company on telemedicine

Insights

VIEW ALL